Anmeirui International Pharmaceutical Holding Group (API) is an overseas registered R&D high-tech investment group. Its holding industry involves import and export, real estate, biopharmaceuticals, chemicals, R&D and health care products production and many other fields. Qingdao Anmeirui Biotechnology Industry Group, controlled by Anmeirui International Pharmaceutical Holding Group (API for short), exclusively enjoys the production formula and technology of health care products, and produces and sells "Anmeirui" series of health care products with international brand of API in Chinese mainland. The group is divided into Qingdao Aimeirui Biotechnology Co., Ltd., Qingdao Baifude Technology Co., Ltd. and Qingdao Guhaiyuan Biotechnology Co., Ltd., with GMP certification factories for food and drug. Since its establishment, the Group has always implemented the enterprise development strategy of applying international cutting-edge biotechnology to human healthy life, and constantly tapped the exploitable potential of human survival and development in the future. The company has long-term and extensive cooperation with many well-known foreign companies, and has developed two series of healthy and nutritious foods with international leading level through long-term research and exploration by world-class nutrition experts and professors. This series of products includes more than 50 kinds, 100 varieties. At present, there are 7 kinds of approved health foods (calcium vitamin D3, vitamin E, vitamin C chewable tablets, B vitamins, ferrous gluconate tablets, propolis and spirulina tablets). In addition, the approval of four products (deep sea fish oil, soybean lecithin, soybean isoflavone and aloe) is being declared. Our products sell well in 300 cities in 25 provinces. Baifude Technology Co., Ltd. is a new material industry group of the Group in Qingdao National High-tech Industrial Development Zone (High-tech Zone), with a 30-mu industrial park, a five-story intelligent office building and a 12000 square meter GMP production workshop for food and drugs. Products have been exported to the United States, Japan, Southeast Asia, South Korea and other countries and regions. In 2006, Qingdao Guhaiyuan Biotechnology Co., Ltd. formed a strategic alliance with Boston Corp, the largest health industry group in the United States, and Qingdao Guhaiyuan Biotechnology Co., Ltd. was solely responsible for the promotion and sales of its excellent brand NCB series health products in Chinese mainland. In order to ensure the uniform quality standard of Amry series products, the formula, raw materials, finished products and packaging have undergone extremely strict design, management and inspection, and all the products produced meet the GMP requirements of drugs and food. In today's fierce competition of nutrition and health products, Amry series products have been selling well for four years with its unique formula, rigorous technology, excellent quality, rich cultural connotation and strong support of caring health services, and still become the first choice health brand for consumers in Changsha, Guiyang, Jinan, Changzhou, Hangzhou, Ningbo, Huzhou, Shenyang, Changchun, Beijing and other national markets. Amry, a healthy brand, uses the strictest screening conditions, the highest quality raw materials at home and abroad, the strictest management, the most breakthrough production technology and the most thoughtful sales service to convey the brand concept of "purity, nature and trust" to every consumer.